A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.
Stadler WM, Desai AA, Quinn DI, Bukowski R, Poiesz B, Kardinal CG, Lewis N, Makalinao A, Murray P, Torti FM.
Stadler WM, et al. Among authors: murray p.
Cancer Chemother Pharmacol. 2008 Apr;61(4):689-94. doi: 10.1007/s00280-007-0524-6. Epub 2007 Jun 14.
Cancer Chemother Pharmacol. 2008.
PMID: 17569043
Clinical Trial.